We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

206 hedge funds and large institutions have $64.8M invested in Editas Medicine in 2024 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 61 increasing their positions, 57 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 57

2% more call options, than puts

Call options by funds: $396K | Put options by funds: $388K

5.01% less ownership

Funds ownership: 66.86% → 61.84% (-5%)

10% less funds holding

Funds holding: 229 → 206 (-23)

33% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 58

65% less capital invested

Capital invested by funds: $188M → $64.8M (-$123M)

Holders
206
Holders Change
-23
Holders Change %
-10.04%
% of All Funds
2.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
61
Reduced
57
Closed
58
Calls
$396K
Puts
$388K
Net Calls
+$8K
Net Calls Change
-$354K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$3.7M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$2.87M
3
MAM
Monaco Asset Management
Monaco
+$2.73M
4
UBS Group
UBS Group
Switzerland
+$1.79M
5
AQR Capital Management
AQR Capital Management
Connecticut
+$1.77M

Top Sellers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
-$16.7M
2
APM
Avidity Partners Management
Texas
-$5M
3
Pictet Asset Management
Pictet Asset Management
Switzerland
-$4.02M
4
BlackRock
BlackRock
New York
-$1.83M
5
Millennium Management
Millennium Management
New York
-$1.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
SIS
176
Sound Income Strategies
Florida
$191 – – –
BBPWM
177
Blue Bell Private Wealth Management
Pennsylvania
$177 – – –
RIL
178
Rothschild Investment LLC
Illinois
$165 +$268 +105 +420%
MPWT
179
MassMutual Private Wealth & Trust
Connecticut
$152 +$306 +120 New
CA
180
CoreCap Advisors
Michigan
$146 -$548 -215 -65%
PMFA
181
Plante Moran Financial Advisors
Michigan
$127 – – –
VCM
182
Versant Capital Management
Arizona
$127 – – –
BHWM
183
Beaird Harris Wealth Management
Texas
$102 – – –
CFGS
184
Concourse Financial Group Securities
Alabama
$100 – – –
CA
185
Clearstead Advisors
Ohio
$97 +$130 +51 +204%
KFI
186
Key Financial Inc
Pennsylvania
$95 – – –
MBFW
187
Morton Brown Family Wealth
Pennsylvania
$83 – – –
TC
188
Truvestments Capital
Florida
$77 – – –
PA
189
Parallel Advisors
California
$76 – – –
DIP
190
DT Investment Partners
Pennsylvania
$69 – – –
GWP
191
Gen-Wealth Partners
Michigan
$67 – – –
CFFP
192
Center for Financial Planning
Michigan
$64 – – –
NRG
193
Nemes Rush Group
Michigan
$64 – – –
NSIM
194
North Star Investment Management
Illinois
$48 – – –
IA
195
IFP Advisors
Florida
$43 +$87 +34 New
CTA
196
Colonial Trust Advisors
South Carolina
$38 – – –
MCM
197
MAI Capital Management
Ohio
$28 +$56 +22 New
HI
198
Harbour Investments
Wisconsin
$24 – – –
FP
199
Financial Perspectives
Minnesota
$8 – – –
GWSG
200
GPS Wealth Strategies Group
Colorado
$3 -$15 -6 -75%
6 7
8
9 10

EDIT Hedge Fund Activity: Q4 2024 in Review

206 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q4 2024, worth a combined $64.8M — down 65% from $188M a quarter earlier.

Sellers outnumbered buyers: 58 funds closed out of EDIT and 39 opened new positions — a net loss of 19 holders — while 57 trimmed existing stakes and 61 added.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $3.7M. The largest seller was Deep Track Capital, exiting entirely with an estimated $16.7M sold.

  • 206 institutional investors held Editas Medicine (EDIT) as of Q4 2024, down from 229 in Q3 2024.
  • Funds reported $64.8M of Editas Medicine stock for Q4 2024, down 65% quarter-over-quarter.
  • 39 funds opened new Editas Medicine positions in Q4 2024 and 58 closed out, a net change of -19 holders.
  • The largest Editas Medicine buyer in Q4 2024 was Renaissance Technologies, an estimated $3.7M added.
  • The largest Editas Medicine seller in Q4 2024 was Deep Track Capital, an estimated $16.7M sold.

Based on aggregated 13F filings for Q4 2024.